133
Views
3
CrossRef citations to date
0
Altmetric
Research Articles

Structural debilitation of mutation G322D associated with MSH2 and their role in triple negative breast cancer

, &
Pages 771-780 | Received 12 Dec 2018, Accepted 22 Feb 2019, Published online: 19 Mar 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Parth Sarthi Sen Gupta, Rifat Nawaz UI Islam, Sahini Banerjee, Arnab Nayek, Malay Kumar Rana & Amal Kumar Bandyopadhyay. (2021) Screening and molecular characterization of lethal mutations of human homogentisate 1, 2 dioxigenase. Journal of Biomolecular Structure and Dynamics 39:5, pages 1661-1671.
Read now
Utkarsh Nagpal, D. Kamalesh, P. Raghuraman, Sriroopreddy Ramireddy & C. Sudandiradoss. (2021) Delineating the folding perturbations and molecular mechanisms of Thr-Ala 642 mutation in Rab-GTPase activating protein Akt substrate of 160kDa and its impact on the aetiology of diabetes. Journal of Biomolecular Structure and Dynamics 39:2, pages 409-420.
Read now

Articles from other publishers (1)

Ramireddy Sriroopreddy, P. Raghuraman, J. Sreeshma, D. Kamalesh & C. Sudandiradoss. (2021) Exploring the structural significance of molecular switch mechanism alias motif phosphorylation in Wnt/β-catenin and their crucial role in triple-negative breast cancer. Archives of Biochemistry and Biophysics 698, pages 108722.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.